ELV - CIK 0001156039
Elevance Health, Inc. trades as ELV and has a market capitalization of $87.59 B, making it the #180 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $199.13B, up 12.5% from the prior year and net income of $5.66B. This page tracks Elevance Health, Inc. through 1,000 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 9 fiscal years Elevance Health, Inc.'s revenue grew from $84.86B to $199.13B, a compound annual growth rate of 9.9%. Net profit margin compressed from 2.9% to 2.8% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-20 |
| Insider sale notice | 144 | 2026-05-19 |
| Insider trade | 4 | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
Elevance Health supports health at every life stage, offering health plans and clinical, behavioral, pharmacy, and complex-care solutions that promote whole health.
The largest companies sharing Elevance Health, Inc.'s SEC industry classification (hospital & medical service plans).
Elevance Health, Inc. (ELV) has a market capitalization of $87.59 B as of 2026-06-10, ranking #180 among US-listed companies.
Elevance Health, Inc. reported revenue of $199.13B for fiscal year 2025, an increase of 12.5% year over year.
Yes. Elevance Health, Inc. reported net income of $5.66B in its latest fiscal year.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.